Why the study?
Does the MELD-XI score predict no-reflow phenomenon and short-term mortality in patients with STEMI undergoing primary PCI?
Does the MELD-XI score predict no-reflow phenomenon and short-term mortality in patients with STEMI undergoing primary PCI?
Answers are grounded in this paper and cite their sources.
The MELD-XI score serves as an inexpensive and readily available tool for risk stratification in STEMI patients undergoing primary PCI.
The MELD-XI score can be used to predict NRP and the 30-day prognosis in patients with STEMI who are candidates for primary PCI. It could be adopted as an inexpensive and a readily available tool for risk stratification.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: